If the cytosolic TK2-like enzyme described here is encoded by a different gene it may contribute to and help to explain the therapeutic effects of deoxynucleoside treatment in TK2 knock-out mouse models as well as in human patients with TK2 deficiency [33–35, 37, 38]. Here, TK2 is linked to hyperinsulinemic hypoglycemia, familial, 4.